Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study (Q46213930)

20 December 2017

title

Efficacy of a vitamin/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study (English)

1 reference

20 December 2017

0 references

1 reference

Ruth Remington

1 reference

20 December 2017

Amy Chan

series ordinal

1 reference

20 December 2017

James Paskavitz

series ordinal

1 reference

20 December 2017

Thomas B Shea

series ordinal

1 reference

20 December 2017

language of work or name

English

0 references

publication date

3 December 2008

1 reference

20 December 2017

American Journal of Alzheimer's Disease & Other Dementias

published in

1 reference

20 December 2017

volume

1 reference

20 December 2017

issue

1 reference

20 December 2017

page(s)

27-33

1 reference

20 December 2017

Treatment of Alzheimer's disease across the spectrum of severity

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Activities of daily living in moderate-to-severe Alzheimer disease: an analysis of the treatment effects of memantine in patients receiving stable donepezil treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Pharmacotherapy of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Is functional decline necessary for a diagnosis of Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Prevention trials in Alzheimer disease: one step forward?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Evidence supporting nutritional interventions for persons in early stage Alzheimer's disease (AD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Presenilin 1 gene silencing by S‐adenosylmethionine: a treatment for Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Acetyl-1-carnitine. 2: Effects on learning and memory performance of aged rats in simple and complex mazes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Folate deprivation increases presenilin expression, gamma-secretase activity, and Abeta levels in murine brain: potentiation by ApoE deficiency and alleviation by dietary S-adenosyl methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Dietary and genetic compromise in folate availability reduces acetylcholine, cognitive performance and increases aggression: critical role of S-adenosyl methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Effects of S-adenosyl-L-methionine on lipid peroxidation and glutathione levels in rat brain slices exposed to reoxygenation after oxygen-glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Folate, vitamin E, and acetyl-L-carnitine provide synergistic protection against oxidative stress resulting from exposure of human neuroblastoma cells to amyloid-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Protective effect of N-acetyl-L-cysteine on amyloid beta-peptide-induced learning and memory deficits in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Dietary supplementation with 3-deaza adenosine, N-acetyl cysteine, and S-adenosyl methionine provide neuroprotection against multiple consequences of vitamin deficiency and oxidative challenge: relevance to age-related neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Effect of S-adenosyl-L-methionine on rat brain oxidative stress damage in a combined model of permanent focal ischemia and global ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Effects of dietary supplementation with N-acetyl cysteine, acetyl-L-carnitine and S-adenosyl methionine on cognitive performance and aggression in normal mice and mice expressing human ApoE4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Folate quenches oxidative damage in brains of apolipoprotein E-deficient mice: augmentation by vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Normative data for the Mattis Dementia Rating Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Clinical validity of the Mattis Dementia Rating Scale in detecting dementia of the Alzheimer type: a double cross-validation and application to a community-dwelling sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

CLOX: an executive clock drawing task

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Clock drawing and frontal lobe behavioral effects of memantine in Alzheimer's disease: a rater-blinded study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

The Neuropsychiatric Inventory: assessing psychopathology in dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Assessment of behavioural and psychological symptoms associated with dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Impact of behavioural problems on spousal caregivers: a comparison between Alzheimer's disease and frontotemporal dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

What causes problems in Alzheimer's disease: attributions by caregivers. A qualitative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Caregiver's distress is associated with delusions in Alzheimer's patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Donepezil in more advanced Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Donepezil preserves cognition and global function in patients with severe Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

A systematic review of assessment and treatment of moderate to severe Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Alzheimer's disease - the ways of prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Causes of oxidative stress in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

Agitation in demented patients in an acute care hospital: prevalence, disruptiveness, and staff burden

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1533317508325094

21 January 2018

Identifiers

DOI

10.1177/1533317508325094

1 reference

20 December 2017

1 reference

20 December 2017